Ignite Creation Date:
2025-12-24 @ 5:28 PM
Ignite Modification Date:
2026-01-18 @ 12:10 PM
Study NCT ID:
NCT05838768
Status:
RECRUITING
Last Update Posted:
2025-09-03
First Post:
2023-04-05
Is NOT Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
Study of HRO761 Alone or in Combination in Cancer Patients With Specific DNA Alterations Called Microsatellite Instability or Mismatch Repair Deficiency.
Sponsor:
Novartis Pharmaceuticals
Organization:
Conditions & Keywords Data
Conditions:
Conditions
| Condition Brief | Condition Text | View |
|---|---|---|
| None | MSIhi or dMMR Advanced Unresectable or Metastatic Solid Tumors, Including … | View |
Keywords:
Keywords
| Keyword Brief | Keyword Text | View |
|---|---|---|
| None | Phase I/Ib | View |
| None | MSIhi (Microsatellite Instability-High) | View |
| None | dMMR (Mismatch Repair Deficient) | View |
| None | solid tumors | View |
| None | CRC (Colorectal cancer) | View |
| None | advanced cancer | View |
| None | metastatic | View |
| None | HRO761 | View |
| None | pembrolizumab | View |
| None | irinotecan | View |